08.08.25 -- Tech Transfer 2025 – A High-Stakes Game Of Trust

Explore the significance of human factors in the development of medical devices by illustrating the importance of incorporating end users in the process.

By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.

Examine combination case studies that demonstrate bevacizumab paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

The FDA announced on May 6, 2025, that it intends to expand its use of unannounced inspections at foreign manufacturing facilities. Here are key considerations and actions to take in order to be prepared.

In this webinar, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.

Delve into the growing interest in methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

Ensure pharmaceutical tablet safety and efficacy through batch testing, including breaking force, friability, disintegration, and dissolution analyses aligned with strict regulatory standards.

We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.